Skip to main content
Log in

Newborn screening for severe combined immunodeficiency cost effective in the Netherlands?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. T-cell receptor excision circle (TREC) detection was performed using the SPOT-it [ImmunoIVD] kit.

  2. 2020 values

Reference

  • van den Akker-van Marle ME, et al. Economic Evaluation of Different Screening Strategies for Severe Combined Immunodeficiency Based on Real-Life Data. International Journal of Neonatal Screening : 15 Sep 2021. Available from: URL: https://doi.org/10.3390/ijns7030060

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Newborn screening for severe combined immunodeficiency cost effective in the Netherlands?. PharmacoEcon Outcomes News 889, 19 (2021). https://doi.org/10.1007/s40274-021-08107-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-08107-2

Navigation